- Home
- TLRY vs ALVO Comparison
TLRY vs ALVO Comparison
Compare TLRY & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$11.41
HOLD
Current Price
$5.51
Company Overview
Basic Information| Metric | TLRY | ALVO |
|---|---|---|
| Founded | N/A | 2013 |
| Country | Canada | Luxembourg |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.6B |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | TLRY | ALVO |
|---|---|---|
| Price | $11.41 | $5.51 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $150.00 | $9.25 |
| AVG Volume (30 Days) | ★ 9.5M | 544.5K |
| Earning Date | 01-09-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.24 |
| Revenue | ★ $830,766,000.00 | $573,350,000.00 |
| Revenue This Year | $7.28 | $20.97 |
| Revenue Next Year | $4.51 | $43.04 |
| P/E Ratio | ★ N/A | $23.19 |
| Revenue Growth | 2.31 | ★ 45.55 |
| 52 Week Low | $3.51 | $4.32 |
| 52 Week High | $23.20 | $13.70 |
Technical Indicators
Market Signals| Indicator | TLRY | ALVO |
|---|---|---|
| Relative Strength Index (RSI) | 86.25 | 47.61 |
| Support Level | $7.10 | $5.40 |
| Resistance Level | $8.64 | $5.85 |
| Average True Range (ATR) | 0.73 | 0.31 |
| MACD | 0.78 | 0.15 |
| Stochastic Oscillator | 90.74 | 77.78 |
Price Performance
Historical Comparison TLRY
ALVO
About TLRY Tilray Brands Inc.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mostly from alcohol.
About ALVO Alvotech
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases.